205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
67.24%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
-16.67%
Both reduce yoy D&A, with AVGO at -0.37%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
6.25%
Lower deferred tax growth vs. AVGO's 17.96%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
21.12%
Well above AVGO's 18.76% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
-111.41%
Negative yoy inventory while AVGO is 26.35%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
64.52%
Growth well above AVGO's 68.61%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-96.42%
Both negative yoy, with AVGO at -33.99%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-62.05%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
49.15%
Some CapEx rise while AVGO is negative at -44.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
37.20%
Purchases well above AVGO's 45.71%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-33.69%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
47.66%
Investing outflow well above AVGO's 23.56%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-66.67%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
1.18%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.